UBS strategists see a potential year-end rally in US equities, driven by a combination of seasonal trends, strong investor sentiment, and the possibility of reduced market volatility. The investment ...
UBS analyst Trung Huynh maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $31.00. The ...
Swiss money manager cuts mid-2025 and end-2025 targets for MSCI China Index because of tariff uncertainties and disappointing ...
Ibotta (NYSE:IBTA) stock tumbled 20% in premarket trade, as UBS downgraded the company to Neutral citing lack of growth ...
This acquisition highlights UBS’s strategic interest in Tritax EuroBox ... For further insights into GB:EBOX stock, check out TipRanks’ Stock Analysis page. Trending Articles Tritax EuroBox NewsMORE ...
We recently made a list of UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks. In this piece, we will take ...
Fintel on MSN9h
UBS Upgrades 3M (MMM)
Fintel reports that on November 13, 2024, UBS upgraded their outlook for 3M (NYSE:MMM) from Neutral to Buy. Analyst Price ...
We recently made a list of UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks. In this piece, we will take ...
UBS Global Wealth Management has cut its forecast for Chinese equities due to rising concerns over potential US tariffs and a ...
Scott Stackman and Lyle Casriel’s team at UBS focus on building durable portfolios supplemented by alternatives like private ...